Posts Tagged ‘birth control’
Founder Reflections on 2023
As I reflect on this past year, 2023 finally brought us some wins in reproductive health. And I personally had the opportunity to contribute to landmark steps forward. ⭐️ The FDA made long awaited changes to the mifepristone REMS program to allow pharmacies to dispense the essential medication. I was part of the research team…
Read MoreOver-the-Counter Birth Control Pills: FDA Considering HRA Pharma’s Opill
Why Over-the-Counter Birth Control? Oral contraceptives have been around since 1960, and their risks and safety profiles have been well-studied throughout the years. According to the Guttmacher Institute, unplanned pregnancies account for 45% of all pregnancies in the US. Furthermore, nearly one-third of individuals who have tried to obtain a prescription for hormonal contraception report…
Read MoreUpdated Report on State Policy Efforts to Expand Access to Contraception in Pharmacies
Download free 22-page report describing the current landscape of direct access to contraception in pharmacies, state policy approaches and experiences, as well as implementation.
Read MoreLevonorgestrel Intrauterine Device for Emergency Contraception
A new research study evaluates levonorgestrel IUD for emergency contraception
Read MoreMeet Phexxi – A New Non-Hormonal Contraceptive Gel
About the Product Lactic acid, citric acid, and potassium bitartrate (Phexxi, Evofem Biosciences) is a prescription combination, non-hormonal contraceptive gel approved by the FDA in May 2020. The vaginal gel was found to be 86.3% effective with typical use when inserted up to 1 hour before vaginal intercourse.1 The gel acts as a contraceptive by…
Read MoreContraception During COVID-19: Pharmacy Best Practices
Pharmacists should not allow postponed or cancelled appointments to keep patients from accessing birth control. It’s important that patients understand how their pharmacy can continue to meet their contraceptive needs during the coronavirus disease 2019 (COVID-19) pandemic. Pharmacists should inform patients that even though clinics and providers’ offices might be closed, their pharmacy is still…
Read MoreClinical Considerations for Contraception During COVID: Extended Duration of IUDs and Implants
During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.
Read More5 Pearls from the 2020 States Forum on Pharmacist Birth Control Services
The second annual States Forum on Pharmacist Birth Control Services recently was held by the Birth Control Pharmacist project in partnership with the National Alliance of State Pharmacy Associations (NASPA). Due to the coronavirus disease 2019 (COVID-19) pandemic, this year’s meeting was held virtually as representatives from across the United States, as well as Canada,…
Read MoreClinical Considerations for Contraception During COVID: Patient Self-Administration
During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.
Read More2020 CDC Update for Contraceptive Use in Women at High Risk for HIV
The CDC published updated guidelines to the 2016 U.S. Medical Eligibility Criteria for Contraceptive Use regarding women at high risk for HIV infection in April 2020.
Read More